New ‘weight-loss' drugs have lower impact in real life compared to clinical trial results: study
A recent study done in the U.S. showed that semaglutide and tirzepatide — injectable GLP-1 drugs for obesity — produce lower weight loss in a real-world setting, than during the clinical trial, because patients discontinue treatment or use lower maintenance dosages.
The results were published by researchers from the Cleveland Clinic, Ohio, U.S., in the peer-reviewed journal Obesity on June 10. Semaglutide and tirzepatide are FDA-approved medications for the treatment of type 2 diabetes and chronic weight management and are now also available in India.
Hamlet Gasoyan et al accessed electronic health record data from a large health system in Ohio and Florida to identify adults with overweight or obesity without type 2 diabetes who started with injectable semaglutide or tirzepatide between 2021 and 2023. They recorded early discontinuation (within 3 months) and late discontinuation (within 3–12 months) along with weight reduction. The researchers observed that treatment discontinuation and use of lower maintenance dosages might reduce the likelihood of achieving clinically-meaningful weight reduction in patients on these drugs.
Researchers also identified the factors associated with higher odds of achieving a weight loss of 10% or more, after one year of treatment — continuing medications or discontinuing late (vs. early), taking a high maintenance dosage, getting tirzepatide (vs. semaglutide) and were female (vs. male).
Commenting on the results of the study, V. Mohan, senior diabetologist, and chairman, Dr. Mohan's Diabetes Specialties Centre, Chennai, who has initiated patients on weight-loss drugs, says: 'The findings are not surprising because in a randomised clinical trial (RCT), there is constant follow up with the participants to continue with the drug regimen. On the other hand, in the real world, especially if patients buy their own medication, they often stop the drug. Even otherwise, compliance rates in real world are much poorer than in an RCT. The bottom line is that these drugs work as long as they are taken. That is how it is with most drugs, if you stop statins, for instance, cholesterol levels go up; if you stop anti-diabetic drugs or BP drugs, the sugar and BP go up.'
'A reality check'
Anoop Misra, who heads Fortis C-DOC Hospital for Diabetes and Allied Sciences in Delhi, who has also put his patients on these class of drugs, says: 'This study gives us a reality check of weight loss and blood sugar lowering effects of these drugs. It is important to note that discontinuation of such drugs is likely to be more in India, driven also by cost concerns. Non-compliance to diet and exercise are additional reasons to be considered in India which may cause lower weight loss.'
'Our findings about the real-world use patterns of these medications and associated clinical outcomes could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions,' said Dr. Gasoyan.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Haryana records decline in sale of pregnancy termination kits: officials
The sale of Medical Termination of Pregnancy (MTP) has declined sharply over the past three months from 40,763 in the first fortnight of March to just 470 kits between May 27 and June 9, according to Haryana Food and Drugs Administration (FDA) Department data. Officials attribute the success to the ongoing crackdown by the State Task Force (STF) on illegal abortions in the state, battling a skewed sex ratio. Concerned over the state's declining sex ratio — 910 girls per 1,000 boys at birth in 2024, the lowest in eight years — authorities have intensified crackdown on the illegal sale of MTP kits and monitoring transaction of kits from authorised wholesalers. Haryana has 32 authorised wholesalers selling MTP kits to registered MTP centres. According to data, between March 1 and 15, Haryana recorded the sale of 40,763 MTP kits, with a staggering 39,000 kits sold in Sonipat district alone. The trend continued in the first fortnight of April, recording the sale of 25,721 kits, but drastically declined in the second fortnight, with only 1,492 kits sold. The sale of MTP kits dropped further to just 470 between May 27 and June 9. State Drug Controller Manmohan Taneja told The Indian Express, 'Wholesalers have been strictly instructed to sell MTP kits only to authorised MTP centres on the recommendation of a registered medical practitioner. We have mandated record-keeping for every tablet, and any violations will be dealt with strictly.' During an STF meeting, chaired by Haryana Additional Chief Secretary for Health Sudhir Rajpal on Tuesday, officials reported: 'Twenty-nine wholesalers recorded zero sale of MTP kits between June 3 and 9.' In April, Rajpal directed authorities to compile lists of wholesalers of MTP kits, along with records of their stocks, to ensure the sales are restricted only to registered MTP centres. He also ordered inspections of centres conducting MTP procedures on pregnant women who have two girl children, and warned centres found guilty of conducting female feticide would face closure. Rajpal stressed the urgent need for action on show-cause notices issued to MTP centres, urging immediate cancellation of licenses of gynaecologists found complicit in sex-selective abortions. Officials said terminating a pregnancy could be done surgically or with M TP kits, but self-administering these medications without medical supervision posed severe health risks. Taneja previously explained that an MTP kit consists of five tablets—one mifepristone and four misoprostol — both classified as Schedule-H drugs, meaning a valid prescription from an RMP is required for the purchase of a kit that comes with a warning: 'To be used only under the direct supervision of a gynaecologist.' Officials believe the impact of the ongoing initiatives will start delivering results by August-September, leading to an improvement in the sex ratio at birth. From June 3 to 9 this year, the child sex ratio at birth was recorded at 943 girls per 1,000 boys. During the STF meeting on May 20, the sex ratio for the preceding week was noted at 922, while on April 10, it stood at 911 girls per 1,000 boys. However, officials involved in the campaign emphasised these figures reflect temporary fluctuations and suggested waiting a few more months to assess a meaningful and sustained change in the sex ratio at birth.
Hindustan Times
5 hours ago
- Hindustan Times
MTP kit sales plummet in Haryana after crackdown
Following a state-wide crackdown on the sale of abortion pills--both legal and illegal--in the last four months, there has been a dramatic fall in the demand for medical termination of pregnancy (MTP) kits across Haryana, official data shows. From a peak of 40,763 MTP kits supplied by 32 wholesalers in the first fortnight of March, across 22 districts to retail medical shops and the certified MTP centres, the figures have nosedived to near-zero in at least 19 districts by early June, according to the official data compiled by the state Food and Drugs Administration (FDA). The data shows that 30,877 MTP kits were sold by the wholesalers in the second fortnight of March, and it came down to 25,721 between April 1 and April 15. Of the total 1,02,752 MTP kits sold between March 1 and June 9, as many as 87,770 MTP kits were sold by two Sonepat based wholesalers. While 10 districts have one each wholesaler, Ambala and Faridabad district have five each wholesalers of MTP Kits, followed by four in Panchkula and three each in Gurugram and Rohtak. This crackdown, spearheaded by additional chief secretary (health) Sudhir Rajpal, is a part of a broader strategy to prevent sex-selective abortions through coordinated monitoring. After Rajpal set up the State Task Force (STF) on February 6 and began cracking the whip to improve Haryana's sex ratio at birth (SRB) under the flagship Beti Bachao-Beti Padhao campaign, authorities have also seized about 8,800 MTP kits being sold illegally, registered over 50 FIRs, including at least 18 against online sellers of the MTP kits. According to Haryana state drug controller Manmohan Taneja, the FDA's data analysis shows 'no recorded sales of MTP kits in several key periods after mid-May', with the exception of a few pockets such as Gurugram, Faridabad, Ambala and Yamunanagar, which still reported some activity, though far reduced. 'The FDA has directed the wholesalers not to sell MTP kits to medical shops even as they can directly supply the kits to registered MTP centres. Ever since the crackdown began, we have been tracking the sale of MTP kits from wholesale suppliers to MTP centers and the patients to whom it was given. Now every MTP kit sold is being tracked up to the patient who was prescribed the medicine by the MTP center,' said Taneja. Enforcement action As per the FDA data, between February 11 and June 9, a total of 27 medical shops were sealed across the state for selling MTP kits illegally. In addition, FIRs were registered against 29 individuals and establishments for violations under the MTP Act and related laws. These included medical stores, nursing homes, and unregistered practitioners operating without authorisation in districts such as Gurugram, Faridabad, Panipat, Palwal and Rohtak. The accused were booked under Sections 3, 4 and 5 of the MTP Act, along with provisions of the Essential Commodities Act and the Drugs and Cosmetics Act, where applicable. The violations under the MTP Act are punishable with rigorous imprisonment ranging from two to seven years. These offences are cognizable, non-bailable, and non-compoundable. FDA officials said the crackdown was aimed at curbing the illegal distribution and misuse of abortion pills, particularly in areas where unregulated sales were rampant. 'We have acted swiftly against violators and will continue our surveillance to ensure that MTP kits are sold only through authorised channels and with valid prescriptions,' an FDA officer said. The steep fall in sales figures is being viewed as a success by the state government in regulating access to abortion drugs, though public health experts have cautioned that legitimate access for women in need must not be hampered in the process.
India Gazette
16 hours ago
- India Gazette
Gujarat CM Bhupendra Patel participates in Yoga Camp at Ahmedabad riverfront under 'Swasth Gujarat, Obesity-Free Gujarat' campaign
Gandhinagar (Gujarat) [India], June 11 (ANI): Gujarat Chief Minister Bhupendra Patel graced the yoga camp held at the Event Centre on the Sabarmati Riverfront in Ahmedabad, a press release from Gujarat CMO said. As part of the celebration of 'International Yoga Day - 2025', a free 'Yoga Camp - Common Yoga Protocol Training' was organised under the joint initiative of the Gujarat State Yoga Board, Ahmedabad Municipal Corporation, and the District Administration under the campaign 'Swasth Gujarat, Obesity-Free Gujarat'. Early in the morning, amid a refreshing atmosphere, over 15,000 citizens enthusiastically participated in the yoga camp. Chief Minister Bhupendra Patel, along with other dignitaries, also performed yoga during the camp. On this occasion, Minister of State for Youth, Cultural Activities, and Home Department, Harsh Sanghavi, stated that the yoga camp was held under the leadership of Chief Minister Bhupendra Patel as part of the 'Swasth Gujarat, Obesity-Free Gujarat' campaign. He noted that, through this campaign, all districts of Gujarat are advancing together to create a new milestone on this year's International Yoga Day. He further emphasised that yoga is a profound symbol of Indian culture. Yoga and pranayama, he said, are not merely physical or mental exercises, but holistic practices that establish a deep connection between the mind, body, and soul. On this occasion, the Minister also appealed to the citizens of all districts of Gujarat to take inspiration from yoga and join the 'Swasth Gujarat, Obesity-Free Gujarat' campaign. At this camp, Shishpal Rajput, Chairman of the Gujarat State Yoga Board and a Yogsevak, along with experienced yoga experts, provided insightful guidance on various practices such as yogasan, pranayam, and meditation. Shishpal emphasised the need to prioritise health in today's fast-paced lifestyle by adopting yoga as a regular practice. He addressed issues like hypertension, obesity prevention, and the nutritional value of different foods, encouraging people to embrace a more energetic and balanced way of life. Along with members of the State Yoga Board, he conducted training on standard yoga and pranayam protocols and provided guidance on regular exercise, stress relief through meditation, and incorporating yoga into daily routines. Notably, in his 'Mann Ki Baat' address, Prime Minister Narendra Modi urged citizens across the nation to combat obesity through the practice of yoga. Aligned with this vision, and under the guidance of Chief Minister Bhupendra Patel, the state government has launched the 'Swasth Gujarat, Obesity-Free Gujarat' campaign. This yoga camp stands as a significant step toward realising that objective. The yoga camp was organized to inspire society to embrace physical, mental, and spiritual well-being through yoga. It sought to promote yoga as a way of life, fostering healthier individuals and a happier, more harmonious society. The event was also attended by Ahmedabad Mayor Smt. Pratibha Jain, District Panchayat President Smt. Kanchanba Vaghela, Member of Parliament from Ahmedabad West Dinesh Makwana, all MLAs, Principal Secretary of the Sports, Youth, and Cultural Activities Department M. Thennarasan, Ahmedabad Municipal Commissioner Banchhanidhi Pani, officials and office bearers of the Ahmedabad Municipal Corporation and District Administration, yoga practitioners, yoga enthusiasts, teachers, youth, senior citizens, and a large number of city residents. (ANI)
